Hepatitis: Screening and Testing Methods

 

<p justify;"="" style="text-align: justify;">The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, haemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

 

  • Serological assays for detection of HV infection
  • Molecular assays for the detection of HV infection
  • Quantitation of HV RNA
  • Genotyping of HV isolates

Related Conference of Hepatitis: Screening and Testing Methods

July 08-09-2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

2nd World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019

World Congress on Pancreatic Cancer and Liver Diseases

| Tokyo, Japan
October 29-30, 2019

World conference on Digestive and Metabolic diseases

Berlin, Germany
November 18-19, 2019

20th World Congress on Gastroenterology

Rome, Italy
March 15-16, 2020

7th World Congress on Hepatitis & Liver Diseases

Osaka, Japan

Hepatitis: Screening and Testing Methods Conference Speakers

Recommended Sessions

Related Journals

Are you interested in